| 000 | 01442cam a22003614a 4500 | ||
|---|---|---|---|
| 001 | 0000050724 | ||
| 003 | 0001 | ||
| 008 | 040701s2004 enka b 101 0 eng | ||
| 015 | _aGBA4-X4524 | ||
| 016 | 7 |
_a101236030 _2DNLM |
|
| 020 | _a0470869984 (hbk. : alk. paper) | ||
| 020 | _a9780470869987 (hbk. : alk. paper) | ||
| 035 | _a(OCoLC)ocm55877555 | ||
| 035 |
_a(OCoLC)55877555 _z(OCoLC)56455782 _z(OCoLC)58598373 |
||
| 040 |
_aDLC _cDLC _dYDX _dWJ7 _dCLU _dNLM _dOCL _dBAKER _dMUQ _dNLGGC _dBTCTA _dYDXCP _dDLC |
||
| 042 | _apcc | ||
| 082 | 0 | 0 |
_a612 .015756 _222 |
| 084 |
_a612.015756 _bBIO |
||
| 245 | 1 | 0 |
_aBiology of IGF-1 _h[Book] : _bits interaction with insulin in health and malignant states / _c[edited by Gregory Bock, Jamie Goode]. |
| 260 |
_aThe Atrium, Southern Gate, Chichester, UK ; _aHoboken, NJ : _bJohn Wiley & Sons, _cc2004. |
||
| 300 |
_aviii, 280 p. : _bill. ; _c24 cm. |
||
| 440 | 0 |
_aNovartis Foundation symposium ; _v262 |
|
| 521 | _aAll. | ||
| 650 | 0 |
_aSomatomedin _xPhysiological effect _vCongresses. |
|
| 650 | 0 |
_aSomatomedin _xPathophysiology _vCongresses. |
|
| 650 | 0 |
_aCarcinogenesis _vCongresses. |
|
| 650 | 1 | 2 |
_aSomatomedins _xphysiology _vCongresses. |
| 650 | 2 | 2 |
_aCarcinogenicity Tests _vCongresses. |
| 650 | 2 | 2 |
_aRisk Assessment _vCongresses. |
| 700 | 1 | _aBock, Gregory. | |
| 700 | 1 | _aGoode, Jamie. | |
| 852 |
_p18332 _90.00 _dBooks |
||
| 999 |
_c156242 _d156242 |
||